Paper40451925
Oncogenic function of growth arrest-specific transcript 5 by competing with miR-423-3p to regulate SMARCA4 in hepatocellular carcinoma.
Kim SY and 6 others. Exp Mol Med, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Oncogenic function of growth arrest-specific transcript 5 by competing with miR-423-3p to regulate SMARCA4 in hepatocellular carcinoma. Papers, record 40451925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40451925
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oncogenic function of growth arrest-specific transcript 5 by competing with miR-423-3p to regulate SMARCA4 in hepatocellular carcinoma.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| MicroRNAs | Major topic |
| DNA Helicases | Major topic |
| Transcription Factors | Major topic |
| Nuclear Proteins | Major topic |
| RNA, Long Noncoding | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Methyltransferases | |
| RNA-Binding Proteins | |
| Adenosine | |
| Carcinogenesis |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NRF-2022R1A2C1091808 | National Research Foundation of Korea (NRF) | PubMed |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32303701 | The SWI/SNF complex in cancer - biology, biomarkers and therapy. | Nat Rev Clin Oncol | 2020 | https://conductscience.org/library/papers/32303701 | PubMed |
| 2 | 32162380 | The roles of mutated SWI/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: A review. | Cell Prolif | 2020 | https://conductscience.org/library/papers/32162380 | PubMed |
| 3 | 37369853 | Regulation and functions of non-m6A mRNA modifications. | Nat Rev Mol Cell Biol | 2023 | https://conductscience.org/library/papers/37369853 | PubMed |
| 4 | 29106616 | MODOMICS: a database of RNA modification pathways. 2017 update. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29106616 | PubMed |
| 5 | 16087271 | Gender-dependent hepatic alterations in H-ras12V transgenic mice. | J Hepatol | 2005 | https://conductscience.org/library/papers/16087271 | PubMed |
| 6 | 29171881 | RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. | Hepatology | 2018 | https://conductscience.org/library/papers/29171881 | PubMed |
| 7 | 36854773 | The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/36854773 | PubMed |
| 8 | 30991448 | HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma. | Hepatology | 2019 | https://conductscience.org/library/papers/30991448 | PubMed |
| 9 | 29386218 | Long Noncoding RNA LINC01234 Functions as a Competing Endogenous RNA to Regulate CBFB Expression by Sponging miR-204-5p in Gastric Cancer. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/29386218 | PubMed |
| 10 | 26163879 | Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma. | Carcinogenesis | 2015 | https://conductscience.org/library/papers/26163879 | PubMed |
| 11 | 27774775 | Galactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo. | Adv Healthc Mater | 2016 | https://conductscience.org/library/papers/27774775 | PubMed |
| 12 | 32782576 | Long non-coding RNA GAS5 in human cancer. | Oncol Lett | 2020 | https://conductscience.org/library/papers/32782576 | PubMed |
| 13 | 29792572 | GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics. | Nucleic Acid Ther | 2018 | https://conductscience.org/library/papers/29792572 | PubMed |
| 14 | 38660664 | Construction of CDKN2A-related competitive endogenous RNA network and identification of GAS5 as a prognostic indicator for hepatocellular carcinoma. | World J Gastrointest Oncol | 2024 | https://conductscience.org/library/papers/38660664 | PubMed |
| 15 | 15050913 | Focus on hepatocellular carcinoma. | Cancer Cell | 2004 | https://conductscience.org/library/papers/15050913 | PubMed |
| 16 | 35116254 | Gain of GAS5 reveals worse prognosis in kidney renal clear cell carcinoma and liver hepatocellular carcinoma from the Cancer Genome Atlas dataset. | Transl Cancer Res | 2021 | https://conductscience.org/library/papers/35116254 | PubMed |
| 17 | 33611339 | The role of m6A modification in the biological functions and diseases. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/33611339 | PubMed |
| 18 | 35736636 | Tumor Suppressive Effects of GAS5 in Cancer Cells. | Noncoding RNA | 2022 | https://conductscience.org/library/papers/35736636 | PubMed |
| 19 | 32251383 | Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. | Nat Nanotechnol | 2020 | https://conductscience.org/library/papers/32251383 | PubMed |
| 20 | 33848519 | LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack. | Cancer Lett | 2021 | https://conductscience.org/library/papers/33848519 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42886458 | LncRNA GAS5 Restrains Hepatocellular Carcinoma by Targeting the miR-18a-5p-CADM2 Axis. | Biochem Genet | 2026 | https://conductscience.org/library/papers/42886458 | PubMed |
| 42306183 | METTL3-Mediated m6A Modification of lncRNA-0949 Drives Microglial Inflammation in an vitro Model of Sepsis-Associated Encephalopathy. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42306183 | PubMed |
| 42288679 | STK39 promotes the evolution cascade of hepatocellular carcinoma by facilitating PKR/NF-κB-mediated macrophage inflammatory response. | Oncogene | 2026 | https://conductscience.org/library/papers/42288679 | PubMed |
| 42100423 | Plasma expression of long non-coding RNA GAS5 and its prognostic significance in newly diagnosed multiple myeloma. | Front Oncol | 2026 | https://conductscience.org/library/papers/42100423 | PubMed |
| 41474641 | Mechanistic Insights and Therapeutic Potential of Small Nucleolar RNA Host Genes in the Carcinogenesis of Hepatocellular Carcinoma. | Cancer Med | 2026 | https://conductscience.org/library/papers/41474641 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40451925
GET https://conductscience.org/api/papers/v1/40451925/references?page=2